Demand for home Covid-19 tests exceeds supply
If you needed a reminder that we are still alive in the midst of a global pandemic, here’s one courtesy of CVS. Friday, the pharmacy chain said Business Insider that the company’s supply of take-home COVID tests are if requested that he goes need to start limiting the number customers can buy both.
Until now, people could buy as many tests as they wanted the retailer, no questions asked. But as of Friday, customers are only allowed to buy six online at one time or four at a time when shopping in-store.. Gizmodo was able to confirm that when purchasing one of the home tests on the CVS website, the maximum number you are allowed to add your basket is six.
CVS has yet to respond to Gizmodo’s request for comment, but the company cited “high demand” for testing as the reason customers were cut. And this request makes sense, both if we consider the businesses and schools trying to keep their own COVID count under control right now, and the way the pandemic is currently wreaking havoc in some states. This week, Alabama reported more than 5,500 new cases of coronavirus in school-aged children, while dozens of unvaccinated adults across the state have died en masse from the disease.
Florida, on the other hand, reports about 22,500 new cases adding to its ranks daily, and more than 200 deaths. Arkansas reports its Intensive care is packed the capacity of citizens coming with boxes of the Delta variant, like Louisiana. Naturally, residents of these areas will be on high alert and potentially purchase more tests as a result.
Aside from increased demand, some of these shortages are due to supply chain issues with manufacturing companies. these home tests, like the Abbott and Ellume diagnostic outfits. Bloomberg reported that customers trying to pass each of these company tests, which are available without a prescription of CVS – will face limits on the number of units they are allowed to take home.
G / O Media may earn a commission
An Abbott spokesperson told the Wall Street Journal that he expects the supply of his home tests to be somewhat limited over the next few weeks as he works on hiring more workers and restarting factory lines that have been slowed down earlier this summer. A spokesperson for Ellume hinted that the company was facing similar problems, telling Bloomberg it was busy “ramping up production” to meet unprecedented demand for its tests.